Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Akamai Technologies, Inc. (AKAM) vs BridgeBio Pharma Inc (BBIO) Price & Performance

Akamai Technologies, Inc.Trade
BridgeBio Pharma IncTrade

Price performance (Past 24H)

Key statistics

Akamai Technologies, Inc. vs BridgeBio Pharma Inc — how do they compare? Akamai Technologies, Inc. trades at $116.57 (market cap $16.77B), while BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B). The key difference: Akamai Technologies, Inc. and BridgeBio Pharma Inc are close in size by market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Akamai Technologies, Inc. nearer its low. Which is the better fit depends on your goals.

AKAMBBIO
Market Cap
$16.77B$16.36B
Sector
TechnologyHealth
52-Week High
$161.14$90.17
52-Week Low
$71.97$47.29
Enterprise Value
$22.75B$18.14B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Akamai Technologies, Inc.

Akamai operates a content delivery network, or CDN, which entails locating servers at the edges of networks so its customers, which store content on Akamai servers, can reach their own customers faster, more securely, and with better quality. Akamai has over 325,000 servers distributed over 4,000 points of presence in more than 1,000 cities worldwide. Its customers generally include media companies, which stream video content or make video games available for download, and other enterprises that run interactive or high-traffic websites, such as e-commerce firms and financial institutions. Akamai also has a significant security business, which is integrated with its core web and media businesses to protect its customers from cyberthreats.

Read more on AKAM

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.

Read more on BBIO